{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:08:51Z","timestamp":1745554131643,"version":"3.40.4"},"reference-count":21,"publisher":"S. Karger AG","issue":"3","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Nephrol"],"published-print":{"date-parts":[[2007]]},"abstract":"<jats:p>Long-term outcomes of combined cinacalcet and paricalcitol therapy for secondary hyperparathyroidism (SHPT) in patients failing traditional therapies with phosphate binders and active vitamin D compound analogs are not well described. We implemented a titration protocol for cinacalcet and paricalcitol and assessed its long-term effects on bone metabolism and disease in hemodialysis (HD) patients. Thirty-five patients were started on 30 mg of cinacalcet daily. After 12 months, median cinacalcet dose was 60 mg. There was a 33% increase in number of patients receiving paricalcitol. Average corrected serum calcium (Ca) decreased from 9.5 to 8.8 mg\/dl (p = 0.003, 95% CI 0.34\u20131.04); phosphorus (P) from 6.2 to 5.5 mg\/dl (p = 0.047, 95% CI 0.01\u20131.34); Ca \u00d7 P product from 58 to 48 (p = 0.001, 95% CI 4.2\u201315.7); and intact PTH (iPTH) from 426 \u00b1 274 to 300 \u00b1 228 pg\/ml (p = 0.03, 95% CI 19.3\u2013401.7). Number of patients achieving three or more K\/DOQI criteria increased by 29% (p = 0.009).<\/jats:p>","DOI":"10.1159\/000101727","type":"journal-article","created":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T10:00:55Z","timestamp":1176372055000},"page":"274-278","source":"Crossref","is-referenced-by-count":8,"title":["Long-Term Outcomes of Cinacalcet and Paricalcitol Titration Protocol for Treatment of Secondary Hyperparathyroidism"],"prefix":"10.1159","volume":"27","author":[{"given":"Eric","family":"Lazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Poma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Stankus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2007,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053%2Fj.ajkd.2004.08.009"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1523-1755.2004.09009.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046%2Fj.1523-1755.64.s87.20.x"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1523-1755.2005.67139.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1681%2FASN.2004060512"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056%2FNEJMoa031633"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2215%2FCJN.00870805"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1525-139X.2005.18318.x"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159%2F000074922"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007%2Fs00467-003-1290-2"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1074%2Fjbc.M201804200"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093%2Fndt%2Fgfh966"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1079%2FBJN2003837"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1365-2362.2005.01487.x"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210%2Fjcem-63-5-1218"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1523-1755.2004.09002.x"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1681%2FASN.2004070573"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093%2Fndt%2Fgfg513"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1523-1755.2005.00596.x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046%2Fj.1523-1755.1998.00782.x"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016%2FS0272-6386%2897%2990131-1"}],"container-title":["American Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/101727","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/101727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:04:43Z","timestamp":1745463883000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000101727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000101727","archive":["Portico"],"relation":{},"ISSN":["0250-8095","1421-9670"],"issn-type":[{"type":"print","value":"0250-8095"},{"type":"electronic","value":"1421-9670"}],"subject":[],"published":{"date-parts":[[2007]]}}}